Medium for high performance mammalian fed-batch cultures

US10138467B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10138467-B2
Application numberUS-201415028989-A
CountryUS
Kind codeB2
Filing dateApr 3, 2014
Priority dateOct 14, 2013
Publication dateNov 27, 2018
Grant dateNov 27, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to new serum- and protein-free culture media. These media are high performance culture media, which notably improve mammalian fed-batch cultures. The present invention also relates to methods for preparing and/or designing the medium, and methods of use thereof.

First claim

Opening claim text (preview).

The invention claimed is: 1. A cell culture medium comprising: 1.7 to 10 mM of NaH 2 PO 4 , 2 to 9 mM of L-Leucine, 1 to 6 mM of L-Lysine, 0 to 3 mM of Glycine, 0.4 to 2 mM of L-Methionine, 1 to 4 mM of L-Glutamic acid, 0.5 to 3 mM of L-phenylalanine, 0.7 to 6 mM of L-proline, 0.7 to 6 mM of L-threonine, 0.5 to 2 mM of L-tryptophan, 1 to 7 mM L-Valine, 0.1 to 1.5 mM of Magnesium Sulfate, 0.1 to 1.05 mM of Calcium Chloride, 0.07 to 0.7 mM of myo-Inositol, 0.8 to 4 mM of Sodium pyruvate, 0.0008 to 0.004 mM of D-Biotin, 0.1 to 1 mM of Choline Chloride, 3 to 9 mM of L-Asparagine, 0.006 to 0.04 mM of Folic acid, 0.03 to 0.15 mM of Niacinamide (B3), 0.015 to 0.15 mM of D-pantothenic acid×½Ca, 1 to 8 mM of L-Serine, 1 to 10 mM of Potassium Chloride, 0.005 to 0.05 mM of Pyridoxine, 0.8 to 2.4 mM of L-Aspartic acid, 0.0003 to 0.003 mM of Riboflavin, 0.008 to 0.04 mM of Thiamine, 7.5 to 10 mg/L of Ferric ammonium citrate, 0.0003 to 0.004 mM of Vitamin B12, 0.008 to 0.04 mM of Hypoxanthine, 0.0015 to 0.006 mM of Thymidine, 0.006 to 0.03 mM of Putrescine, 0.1 to 0.5 mM of Ethanolamine, 0.004 to 0.02 mM of Zinc Sulfate, 0.00004 to 0.0008 mM of Cupric sulfate, 0.5 to 2.0 g/L of poloxamer, 0.7 to 3 mM of L-tyrosine, 0.00001 to 0.00006 mM of Sodium Selenite, 0 to 3 mM of L-Alanine, 1 to 3 mM of L-Arginine, 1 to 3 mM of L-Cysteine, 0.4 to 3 mM of L-Histidine, and 1 to 6 mM of L-Isoleucine. 2. The medium according to claim 1 , further comprising glucose, NaHCO 3 , NaCl, NaOH, or combinations thereof. 3. The medium according to claim 2 , wherein the glucose is at a concentration of about 6 g/L and NaHCO 3 is at a concentration of about 2 g/L. 4. The medium according to claim 1 , wherein the osmolality of the medium ranges from 300 to 330 mOsm/kg. 5. The medium according to claim 1 , wherein the pH of the medium ranges from 6.0-8.0. 6. The medium according to claim 1 , said medium containing Glycine or L-Alanine or both. 7. A method for culturing mammalian cells to obtain a product comprising growing the cells in the medium of claim 1 . 8. A method of producing a protein comprising growing a recombinant CHO cell line in the medium of claim 1 and recovering the protein expressed by said cell line from said medium. 9. The medium according to claim 1 , wherein said medium is serum-free and protein-free.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10138467B2 cover?
The present invention relates to new serum- and protein-free culture media. These media are high performance culture media, which notably improve mammalian fed-batch cultures. The present invention also relates to methods for preparing and/or designing the medium, and methods of use thereof.
Who is the assignee on this patent?
Ares Trading Sa
What technology area does this patent fall under?
Primary CPC classification C12N5/0031. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).